Zobrazeno 1 - 9
of 9
pro vyhledávání: '"I. V. Droshneva"'
Autor:
A. A. Kachmazov, L. V. Bolotina, A. L. Kornietskaya, Yu. B. Karagodina, I. V. Droshneva, A. A. Fedenko
Publikováno v:
Тазовая хирургия и онкология, Vol 10, Iss 3-4, Pp 73-83 (2020)
Combination of neoadjuvant chemoradiotherapy with subsequent total mesorectum excision and 6-months of adjuvant chemotherapy remains a standard approach to treatment of locally advanced rectal cancer (T3 or T4 and / or N1–3; M0) for more than 15 ye
Externí odkaz:
https://doaj.org/article/d7b9aee60ddc438080a0b533e7d73f8d
Publikováno v:
Тазовая хирургия и онкология, Vol 0, Iss 1, Pp 7-8 (2015)
Представленные медицинские рекомендации посвящены результатам лечения 1101 больного раком прямой кишки различными вариантами комбинир
Externí odkaz:
https://doaj.org/article/86c1b57d1e1a4f038e2ac685acb2da8b
Autor:
D. G. Sukhin, S. S. Pirogov, A. S. Vodoleev, E. S. Karpova, I. B. Perfilyev, V. V. Veselov, T. V. Belyaeva, O. K. Yutsevich, I. V. Droshneva, V. V. Varvarin
Publikováno v:
Experimental and Clinical Gastroenterology. :103-109
Publikováno v:
Kazan medical journal. 93:52-56
Aim. To study the effect of chemoradiotherapy on the latency of genital nerves and contractility of the anal sphincter in patients with rectal cancer. Methods. Analyzed were 20 cases of rectal cancer T2-3NXM0 (12 males, 8 females). Complex treatment
Publikováno v:
Voprosy onkologii. 58(4)
The total of 296 T3-4NO-2 Federal Coloproctology Science Center colon cancer patients received treatment since 2004 to 2011, 165 patients (main group) also received treatment (pre- and postoperative irradiation, surgery, adjuvant chemotherapy) in P.A
Publikováno v:
Vestnik rentgenologii i radiologii. (5)
Despite the international experience enriched in the number of observations of combination treatment in patients with rectal cancer, many issues remain to be the subject-matter of the discussion. This also applies to the estimation of the value of tu
Publikováno v:
Vestnik khirurgii imeni I. I. Grekova. 170(4)
An analysis of complex treatment of 154 patients with T2-4N0-2 stage rectal cancer is presented who were given preoperative chemoradiotherapy in regimen of dynamic functioning with total focal dose 39.5 Gy (71 patients of the first group) and 47 Gy (
Publikováno v:
Voprosy onkologii. 57(2)
Complex treatment included preoperative radiochemotherapy (fractionated TTD of 47 Gy), 5-FU 2.75-3.5 g, cisplatin 90 mg, surgery and postoperative adjuvant chemotherapy (XELOX). The radiochemotherapy/ surgery interval ranged 21-72 days (average--40;
Autor:
V. M. Khomjakov, I. V. Droshneva, S. O. Stepanov, V. V. Nemudrov, V. I. Kazakevitch, D. V. Sidorov, D. V. Romanov, L. A. Vashahmadge, L. A. Mitina
Publikováno v:
Ultraschall in der Medizin - European Journal of Ultrasound. 26